164 related articles for article (PubMed ID: 8065613)
1. The scientific basis for selection of measures of thrombogenicity.
Lane DA; Bowry SK
Nephrol Dial Transplant; 1994; 9 Suppl 2():18-28. PubMed ID: 8065613
[TBL] [Abstract][Full Text] [Related]
2. Biocompatibility of extracorporeal blood treatment. Selection of haemostatic parameters.
Lindhout T
Nephrol Dial Transplant; 1994; 9 Suppl 2():83-9. PubMed ID: 8065621
[TBL] [Abstract][Full Text] [Related]
3. The investigation of a heart valve patient with suspected hypercoagulability.
Gough SC; Prentice CR
J Heart Valve Dis; 1993 Jan; 2(1):7-17. PubMed ID: 8269113
[TBL] [Abstract][Full Text] [Related]
4. Method for in vitro analysis of nanoparticle thrombogenic properties.
Neun BW; Dobrovolskaia MA
Methods Mol Biol; 2011; 697():225-35. PubMed ID: 21116972
[TBL] [Abstract][Full Text] [Related]
5. Assessment of thrombin generation: useful or hype?
Adams M
Semin Thromb Hemost; 2009 Feb; 35(1):104-10. PubMed ID: 19308898
[TBL] [Abstract][Full Text] [Related]
6. [Interaction of blood and the vascular wall: hemostatic aspects].
Gerlach E; Becker BF
Z Kardiol; 1993; 82 Suppl 5():13-21. PubMed ID: 8154153
[TBL] [Abstract][Full Text] [Related]
7. Activation of coagulation during hemodialysis: effect of blood lines alone and whole extracorporeal circuit.
Lucchi L; Ligabue G; Marietta M; Delnevo A; Malagoli M; Perrone S; Stipo L; Grandi F; Albertazzi A
Artif Organs; 2006 Feb; 30(2):106-10. PubMed ID: 16433843
[TBL] [Abstract][Full Text] [Related]
8. Thrombogenesis.
Nielsen JD
Ann Chir Gynaecol; 1995; 84(4):327-34. PubMed ID: 8687075
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis of intracardiac thrombi by various imaging techniques and activation of platelets and coagulation-fibrinolysis in patients with cardioembolic stroke].
Uchiyama S; Yamazaki M; Iwata M; Maruyama S
Rinsho Shinkeigaku; 1996 Mar; 36(3):429-35. PubMed ID: 8741345
[TBL] [Abstract][Full Text] [Related]
10. The influence of a serine protease inhibitor, nafamostat mesilate, on plasma coagulation, and platelet activation during experimental Extracorporeal Life Support (ECLS).
Mellgren K; Skogby M; Friberg LG; Tengborn L; Wadenvik H
Thromb Haemost; 1998 Feb; 79(2):342-7. PubMed ID: 9493588
[TBL] [Abstract][Full Text] [Related]
11. A guide for diagnosis of patients with arterial and venous thrombosis.
Quinn C; Hill J; Hassouna H
Clin Lab Sci; 2000; 13(4):229-38. PubMed ID: 11586510
[TBL] [Abstract][Full Text] [Related]
12. Platelet coagulation-protein interactions.
Walsh PN
Semin Thromb Hemost; 2004 Aug; 30(4):461-71. PubMed ID: 15354267
[TBL] [Abstract][Full Text] [Related]
13. Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass.
Tabuchi N; de Haan J; Boonstra PW; van Oeveren W
J Thorac Cardiovasc Surg; 1993 Nov; 106(5):828-33. PubMed ID: 8231204
[TBL] [Abstract][Full Text] [Related]
14. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
[TBL] [Abstract][Full Text] [Related]
15. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
Herren T; Straub PW; Haeberli A
Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
[TBL] [Abstract][Full Text] [Related]
16. Comparison of minimally invasive closed circuit extracorporeal circulation with conventional cardiopulmonary bypass and with off-pump technique in CABG patients: selected parameters of coagulation and inflammatory system.
Wippermann J; Albes JM; Hartrumpf M; Kaluza M; Vollandt R; Bruhin R; Wahlers T
Eur J Cardiothorac Surg; 2005 Jul; 28(1):127-32. PubMed ID: 15939621
[TBL] [Abstract][Full Text] [Related]
17. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
Bombeli T; Raddatz-Mueller P; Fehr J
Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
[TBL] [Abstract][Full Text] [Related]
18. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
Elgue G; Blombäck M; Olsson P; Riesenfeld J
Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
[TBL] [Abstract][Full Text] [Related]
19. The role of whole blood in thrombin generation in contact with various titanium surfaces.
Thor A; Rasmusson L; Wennerberg A; Thomsen P; Hirsch JM; Nilsson B; Hong J
Biomaterials; 2007 Feb; 28(6):966-74. PubMed ID: 17095084
[TBL] [Abstract][Full Text] [Related]
20. Changes in molecular markers of hemostatic and fibrinolytic activation under various sampling conditions using vacuum tube samples from healthy volunteers.
Omote M; Asakura H; Takamichi S; Shibayama M; Yoshida T; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Nakao S; Wada T
Thromb Res; 2008; 123(2):390-5. PubMed ID: 18579183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
